Simultaneous determination of propranolol and 4-hydroxypropranolol in plasma by mass fragmentography
Authors:
- Thomas WalleTWThomas Walle
- John MorrisonJMJohn Morrison
- Kristina WalleKWKristina Walle
- Edward ConradiECEdward Conradi
- 1 November 1975
- journal article
- Published by Elsevier in Journal of Chromatography A
- Vol. 114 (2) , 351-359
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- GLC Determination of Propranolol, Other β-Blocking Drugs, and Metabolites in Biological Fluids and TissuesJournal of Pharmaceutical Sciences, 1974
- Rat liver microsomal metabolism of propranolol: Identification of seven metabolites by gas chromatography-mass spectrometryLife Sciences, 1972
- Electron Impact Fragmentation Studies of β-Blocking Drugs and Their Metabolites by GC-Mass SpectroscopyJournal of Pharmaceutical Sciences, 1972
- Effect of route of administration on the relationship between β‐adrenergic blockade and plasma propranolol levelClinical Pharmacology & Therapeutics, 1972
- Relation of Propranolol Plasma Level to β-Blockade during Oral TherapyPharmacology, 1972
- Pharmacology of 4‐hydroxypropranolol, a metabolite of propranololBritish Journal of Pharmacology, 1971
- Plasma Propranolol Levels in the Quantitative Assessment of β-adrenergic Blockade in ManBMJ, 1970
- The pharmacodynamics and metabolism of propranolol in manEuropean Journal of Clinical Pharmacology, 1970
- Surface tension effects of β-adrenergic blocking drugsJournal of Pharmacy and Pharmacology, 1968
- Metabolism of Propranolol (‘Inderal’), a Potent, Specific β-Adrenergic Receptor Blocking AgentNature, 1967